ClinicalTrials.Veeva

Menu

Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer (DLLEB)

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Enrolling

Conditions

Breast Cancer

Treatments

Device: laser alignment
Radiation: Large Segmentation Radiotherapy
Device: Surface guided radiation therapy
Behavioral: free breathing
Device: DIBH

Study type

Interventional

Funder types

Other

Identifiers

NCT06660628
2022-PUMCH-B-116 (Other Grant/Funding Number)
K6433

Details and patient eligibility

About

The study is a single-center, prospective, non-randomized controlled study. The primary objective is to examine the clinical outcomes of utilizing Deep Inspiration Breath Hold (DIBH) in conjunction with hypo-fractionated radiotherapy for patients diagnosed with left-sided breast cancer with a particular focus on its potential to reduce the incidence of cardiac-related clinical and subclinical events.Participants will revieve large segmentation sadiotherapy ± DIBH for left breast cancer and be followed up to gather their clinical cardiac imformation.

Enrollment

348 estimated patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 18-70 years old, female, life expectancy > 5 years
  2. ECOG 0, 1, 2 points
  3. Pathologically diagnosed with left breast cancer and underwent breast-conserving surgery or modified radical mastectomy
  4. The patient will receive radiation therapy to the entire breast or chest wall ± the lymphatic drainage area above and below the clavicle ± the lymphatic drainage area in the axilla.
  5. No prior neoadjuvant chemotherapy or breast reconstruction.
  6. No active cardiac disease, myocardial infarction, or congestive cardiac failure at baseline.
  7. Patients can hold their breath for at least 30 seconds after training
  8. Patients who can be followed up and agree to follow the plan.
  9. Sign the consent form.

Exclusion criteria

  1. Lesions were observed on both sides of the breast.
  2. Diagnosis could not be confirmed by pathology.
  3. Distant metastasis was identified.
  4. The patient had undergone neoadjuvant chemotherapy or breast reconstruction surgery.
  5. Severe cardiac insufficiency; myocardial infarction or uncorrected unstable cardiac arrhythmia or uncorrected unstable angina within the last 3 months; or pericardial disorders
  6. The patient's New York Heart Association (NYHA) cardiac classification is within categories 2-4.
  7. A history of chronic lung disease, including conditions that may contribute to ductal dilatation, such as chronic obstructive pulmonary disease (COPD) and interstitial pneumonia.
  8. Previous mediastinal radiotherapy.
  9. Previous or concurrent second primary malignant tumor (except skin cancer that is not a malignant black pigmented tumor, papillary/follicular carcinoma of the thyroid, carcinoma in situ of the cervix, and contralateral non-invasive breast cancer).
  10. Irradiation of the lymphatic drainage area of the internal breast is required.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

348 participants in 2 patient groups

Surface guided radiation therapy (SGRT) combined with Deep Inspiration Breath Hold (DIBH) technique
Experimental group
Description:
Patients with left breast cancer treated with Surface guided radiation therapy (SGRT) combined with Deep Inspiration Breath Hold (DIBH) technique
Treatment:
Device: Surface guided radiation therapy
Device: DIBH
Radiation: Large Segmentation Radiotherapy
laser alignment combined with free breathing treatment
Active Comparator group
Description:
Patients with left breast cancer treated with traditional laser alignment with free breathing treatment
Treatment:
Behavioral: free breathing
Radiation: Large Segmentation Radiotherapy
Device: laser alignment

Trial contacts and locations

1

Loading...

Central trial contact

Xiaorong Hou

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems